Company intelligence / Profile preview
Evergreen Theragnostics
Springfield, New Jersey, United Statesevergreentgn.com ↗
- Ownership
- Private
- Employees
- ~28
- Development stage
- NDA
01
Overview
OCTEVY™ (Ga‑68 DOTATOC) diagnostic kit targeting neuroendocrine tumors was approaching commercial launch pending FDA approval as of early/mid‑2024. The lead theranostic pair, EVG‑321, includes both Lutetium‑177 and Gallium‑68 labeled agents entering registration-enabling clinical trials for small cell lung cancer. The company also provides CDMO services from preclinical through commercial stages. No pivotal trial results have been published yet.
- Therapeutic areas
- Oncology
- Modalities
- RadiopharmaceuticalPeptides (radiolabeled)Antibody (radiolabeled)Small molecule (radiolabeled)
- Industry
- Biotech
02
Drug pipeline
7 assets6 more assets in the full pipeline.
Request access →03
Partnerships
None publicly disclosed beyond investors and parent company relationships.
Beyond the preview
Go deeper on Evergreen Theragnostics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Evergreen Theragnostics.